Macular degeneration medications are treatments used to slow the progression of macular degeneration—commonly known as age-related macular degeneration (AMD)—and help control vision loss. This condition mostly affects people over the age of 50 and occurs when the macula, a small area in the retina responsible for sharp central vision, becomes damaged over time.
For a more detailed overview of this condition, you can also read our article “What Is Macular Degeneration (AMD)?”
Although macular degeneration cannot currently be completely cured, modern treatment options and macular degeneration medications can significantly slow disease progression and help preserve vision.
Types of Macular Degeneration and Treatment Options
Macular degeneration generally appears in two main forms:
- Dry macular degeneration (Dry AMD)
- Wet macular degeneration (Wet AMD)
The medications and treatment approaches used for these two types are different.
For more information, you can read our related articles:
Medications for Wet Macular Degeneration
Wet macular degeneration is the more aggressive form of the disease and can lead to rapid vision loss. In this type of AMD, abnormal blood vessels develop beneath the retina.
These abnormal vessels may leak fluid or blood, damaging the central vision area.
For this reason, treatment usually involves anti-VEGF medications, which are the most commonly used macular degeneration drugs.
What Is Anti-VEGF Therapy?
Anti-VEGF therapy is a treatment designed to block the growth of abnormal blood vessels in the retina.
This therapy helps to:
- Prevent abnormal blood vessel growth
- Reduce fluid accumulation beneath the retina
- Slow the progression of vision loss
To learn more about treatment approaches, see our article “Wet AMD Treatment Options.”
Most Common Macular Degeneration Medications
Today, the most widely used macular degeneration medications include the following anti-VEGF drugs:
Ranibizumab
Ranibizumab is an anti-VEGF medication that blocks abnormal blood vessel growth in the retina. It is commonly used to slow vision loss in patients with wet macular degeneration.
Aflibercept
Aflibercept is another powerful treatment that helps reduce fluid buildup under the retina and controls abnormal vessel growth.
Bevacizumab
Bevacizumab is also used in some patients to inhibit abnormal blood vessel formation in the retina.
These macular degeneration medications are typically administered through injections directly into the eye, known as intravitreal injections.
Treatment for Dry Macular Degeneration
Dry macular degeneration progresses more slowly and represents the majority of AMD cases.
In this form of the disease, treatment often includes vitamin and mineral supplements designed to support retinal health.
The AREDS Vitamin Formula
The AREDS (Age-Related Eye Disease Study) identified a specific combination of vitamins and minerals that may help slow the progression of macular degeneration.
The AREDS formula typically includes:
- Vitamin C
- Vitamin E
- Zinc
- Lutein
- Zeaxanthin
For some patients, these supplements may help reduce the rate of disease progression.
For more information about the macula itself, you can also read our article “What Is the Macula?”
How Are Macular Degeneration Injections Performed?
Anti-VEGF medications are usually delivered through intravitreal injections, meaning injections directly into the eye.
The procedure generally follows these steps:
- The eye is numbed with anesthetic eye drops
- A sterile environment is prepared
- The medication is injected into the eye
The procedure typically takes only a few minutes, and most patients can return home the same day.
Why Early Diagnosis Is Important
When macular degeneration is diagnosed early, macular degeneration medications and treatments can be much more effective in slowing the disease.
For this reason, individuals over the age of 50 are advised to undergo regular eye examinations.
Early symptoms of macular degeneration may include:
- Blurred vision
- Straight lines appearing distorted
- Difficulty reading
- Dark or empty areas in central vision
If these symptoms occur, it is important to consult an eye specialist as soon as possible.
Trusted Sources for Macular Degeneration Information
For scientifically reliable information about macular degeneration, you can visit:
American Academy of Ophthalmology
https://www.aao.org
National Eye Institute
https://www.nei.nih.gov
Conclusion
Macular degeneration is a common eye condition that primarily affects older adults and can significantly impact central vision. Fortunately, macular degeneration medications, anti-VEGF therapy, and nutritional support can help slow disease progression and protect vision.
With early diagnosis and proper treatment, many patients are able to preserve their vision and maintain a good quality of life.